Lung cancer varies between Caucasians and Asians. There have been differences recorded in the epidemiology, genomics, standard therapies and outcomes, with variations according …
A Mohan, A Garg, A Gupta, S Sahu, C Choudhari… - Lung India, 2020 - journals.lww.com
Materials and Methods: Consecutive lung cancer patients were studied over a 10-year period from January 2008 to March 2018 at the All India Institute of Medical Sciences, New …
India is a land of diversity with a motley of cultures, religions, languages, festivals, and ethnic groups. The country's population as of 2020 is more than 1.38 billion, which accounts for …
Methods: The latest data on lung cancer from the NCRP were collated from 28 population- based cancer registries and 58 hospital-based cancer registries across a five-year (2012 …
S Jiwnani, P Penumadu, A Ashok… - Thoracic Surgery …, 2022 - thoracic.theclinics.com
Low-and middle-income countries (LMICs) 1 have witnessed a rise in mortality due to noncommunicable diseases in the last 2 decades. 2 Although cancer accounted for 9.3 …
A Garg, U Batra, P Choudhary, D Jain… - Current Problems in …, 2020 - Elsevier
Background: The development of various targeted therapies against Epidermal Growth Factor Receptor (EGFR) has been a major step in therapeutic advancements in lung cancer …
A Garg, H Iyer, V Jindal, V Vashistha, A Ali, D Jain… - Lung India, 2022 - journals.lww.com
Background: Indian data on treatment outcomes and survival in advanced non-small cell lung cancer (NSCLC) remain scarce. Materials and Methods: A retrospective review of 537 …
S Rajappa, S Sharma, K Prasad - Advances in therapy, 2019 - Springer
Stage III locally advanced non-small cell lung cancer (LA NSCLC) comprises the most heterogeneous group of patients, accounts for one-third of patients with lung cancer, and is …
BACKGROUND Incidences and mortality of lung cancer are falling in the Western world owing to change in smoking habits and advancement in management with improvement in …